Does the Use of a Nerve Stimulator Improve the Outcome of Ultrasound-Guided Supraclavicular Block (Anesthesia) for Upper Extremity Surgery?
Trial Snapshot
- Phase
- Not Applicable
- Status
- Terminated
- Enrollment
- 8
- Locations
- 2
- Primary Endpoint
- Dermatomes With Complete Motor Block of the Upper Extremities at 30 Minutes
Study Overview
Brief Summary
To help determine if there is improved pain relief when a device that makes an arm muscle move (nerve stimulator) is used to place a needle in the area above the collarbone to prevent feeling of pain (anesthesia) of the upper arm.
Detailed Description
The Investigators will use the assessment of onset of motor and sensory block Q 5 minutes to distinguish the difference between blocks performed with ultrasound guidance with or without a nerve blockade monitor.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 21 Years to 89 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adult male and females 21 through 89
- •Agree to study participation and signed the informed consent
- •Scheduled for upper extremity surgery with ultrasound guided supraclavicular block -
Exclusion Criteria
- •Pregnant Women
- •Persons with allergies to local anesthetics
- •Persons with infections at or near site of needle insertion
- •Patients with severe disturbance of cardiac rhythm and heart block
- •Patients with severe respiratory compromise
- •Patients requiring bilateral upper extremity anesthesia
- •Patients with coagulopathy or medical anticoagulation
- •Patients with traumatic nerve injury to neck or upper extremity
- •Patients with preexisting neurological deficits in the distribution of the block
- •Patients with previous surgery to the neck that may distort brachial plexus anatomy
Outcomes
Primary Outcomes
Dermatomes With Complete Motor Block of the Upper Extremities at 30 Minutes
Time Frame: 30 minutes post block
dermatomes (with full motor block) will be the outcome measure The investigators will be assessing changes between muscle strength in the myotomal distribution of the upper limb corresponding to the dermatome region of the brachial plexus following supraclavicular block, using the MRC power scale (medical research council scale, 0-5), with strength values obtained at time zero (initiation of the block), and to compared to subsequent measurements in 5 minute intervals until the final measurement at 30 minutes following the block.
Secondary Outcomes
No secondary outcomes reported
Investigators
William Grubb, M.D.
Principal Investigator, Associate Professor of Anesthesiology
Rutgers, The State University of New Jersey
